EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 6,080.00
-10.00 (-0.16%)
Sep 19, 2025, 3:30 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 201.14 billion as of September 19, 2025. Its market cap has increased by 56.29% in one year.
Market Cap
201.14B
Enterprise Value
343.61B
Revenue
454.77B
Ranking
n/a
PE Ratio
10.18
Stock Price
6,080.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 201.14B, an increase of 478.68%. That is a compound annual growth rate of 39.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 201.14B | 44.18% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | 211.99B | 509.90% |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.88T |
| Celltrion | 37.63T |
| ALTEOGEN | 25.25T |
| SK Biopharmaceuticals | 8,888.55B |
| Yuhan | 8,872.07B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,202.62B |
| ABL Bio | 5,910.48B |